NAICS 325414 · Biological Product (Except Diagnostic) Manufacturing
6 open opportunities · 542 FY2025 awards · $-18.5M obligated
Top contractors in this NAICS
- Sanofi Vaccines US INC.$87.2M
- Seqirus INC$7.6M
- Seqirus USA INC$6.3M
- Octapharma USA INC$5.5M
- Biogenesis Bago S.A.$3.1M
Hunting recompetes here?
10+ contracts in this NAICS end within 18 months. The largest are listed below — incumbents and end dates included.
All expiring 325414 contracts →Open opportunities
| Title | Agency | Type | NAICS | Posted | Deadline |
|---|---|---|---|---|---|
| GMP Grade Human Interleukin-2 (IL-2) from ACROBiosystems Inc. | NATIONAL INSTITUTES OF HEALTH | Presolicitation | 325414 | Jul 8, 2026 | Jul 17, 2026(2d) |
| 36C255-26-AP-2749 CTL ImmunoSpot S6 Ultra M2 Analyzer - Kansas City VAMC | VETERANS AFFAIRS, DEPARTMENT OF | Special Notice | 325414 | Jul 1, 2026 | Jul 10, 2026 |
| FMD Vaccine Sources Sought | ANIMAL AND PLANT HEALTH INSPECTION SERVICE | Sources Sought | 325414 | Jun 29, 2026 | Jul 29, 2026(14d) |
| TECHNOLOGY LICENSING OPPORTUNITY: PlagueGuard Antibodies | ENERGY, DEPARTMENT OF | Special Notice | 325414 | Dec 5, 2025 | Oct 11, 2025 |
| TECHNOLOGY LICENSING OPPORTUNITY: PlagueGuard Antibodies | ENERGY, DEPARTMENT OF | Special Notice | 325414 | Sep 19, 2025 | Oct 11, 2025 |
| Preparation and Arraying custom BAC Library | — | Modification/Amendment/Cancel | 325414 | Mar 9, 2009 | Mar 23, 2009 |
Largest contracts ending within 18 months
| PIID | Contractor | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|---|
| 75N95025P00265 ↗ | Jackson Laboratory | INDI ALFATAG CELL LINES FOR THE IPSC NEURODEGENETIVE DISEASE INITIATIVE (INDI) PROJECT | National Institutes Of Health | 325414 | $1.5M | Aug 1, 2025 | Jul 31, 2026 |
| 75N92025P00404 ↗ | Vector Biomed INC. | PRODUCTION OF A LENTIVIRAL VECTOR | National Institutes Of Health | 325414 | $653K | Sep 24, 2025 | Sep 23, 2026 |
| 1333ND25PNB640589 ↗ | American Type Culture Collection | OU63-25-NEW-132 MAB RM VIALING | National Institute Of Standards And Technology | 325414 | $338K | Sep 19, 2025 | Apr 2, 2027 |
| 75D30123C18277 ↗ | Lampire Biological Labs INC | RED BLOOD CELLS FROM HORSES, TURKEYS, AND GUINEA PIGS | Centers For Disease Control And Prevention | 325414 | $296K | Sep 22, 2023 | Sep 21, 2026 |
| 75D30122C14299 ↗ | University Of Georgia Research Foundation, INC. | FERRET ANTISERA | Centers For Disease Control And Prevention | 325414 | $250K | Jun 28, 2022 | Sep 28, 2027 |
| 75N93025P01086 ↗ | 10x Genomics, INC. | REAGENTS FOR ONGOING NGS PROJECTS (AMBIS 2270566) | National Institutes Of Health | 325414 | $250K | Sep 29, 2025 | Sep 28, 2026 |
| 75F40125F19001 ↗ | Fujifilm Biosciences INC. | TASK ORDER: HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED CELLS | Food And Drug Administration | 325414 | $247K | Sep 10, 2025 | Sep 8, 2026 |
| 75N90025F00001 ↗ | Roche Diagnostics Corporation | EXERCISE OPTION YEAR 1 | National Institutes Of Health | 325414 | $227K | Sep 1, 2025 | Aug 31, 2026 |
| 12314425P0056 ↗ | Cyagen Biomodels LLC | TO DEVELOP CUSTOMIZED, GENE-TARGETED MOUSE LINES THAT SUPPORT THE STUDY OF PRION ORIGIN, TRANSMISSION, AND STRAIN DIVERSITY IN CERVIDS AND LIVESTOCK, ADVANCING USDA'S RESEARCH AND SURVEILLANCE CAPABILITIES. | Office Of The Chief Financial Officer | 325414 | $198K | Aug 18, 2025 | Aug 17, 2026 |
| 75N94025P00647 ↗ | Government Scientific Source INC | NIDDK SUPPLIES: LAB EQUIPMENT CHROMIUN NEXT GEM SINGLE CELL REACTION KIT - SEVERABLE | National Institutes Of Health | 325414 | $100K | Sep 23, 2025 | Sep 22, 2026 |